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Abstract Fenretinide induces apoptosis in neuroblastoma
by induction of reactive oxygen species (ROS). In this
study, we investigated the role of mitochondria in fenreti-
nide-induced cytotoxicity and ROS production in six
neuroblastoma cell lines. ROS induction by fenretinide was
of mitochondrial origin, demonstrated by detection of
superoxide with MitoSOX, the scavenging effect of the
mitochondrial antioxidant MitoQ and reduced ROS pro-
duction in cells without a functional mitochondrial
respiratory chain (Rho zero cells). In digitonin-permeabi-
lized cells, a fenretinide concentration-dependent decrease
in ATP synthesis and substrate oxidation was observed,
reﬂecting inhibition of the mitochondrial respiratory chain.
However, inhibition of the mitochondrial respiratory chain
was not required for ROS production. Co-incubation of
fenretinide with inhibitors of different complexes of the
respiratory chain suggested that fenretinide-induced ROS
production occurred via complex II. The cytotoxicity of
fenretinide was exerted through the generation of mito-
chondrial ROS and, at higher concentrations, also through
inhibition of the mitochondrial respiratory chain.
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Introduction
N-(4-hydroxyphenyl) retinamide (4HPR), also known as
fenretinide, is a synthetic retinoic acid derivate that induces
apoptosis in a variety of tumors [1–5]. 4HPR induces the
production of reactive oxygen species (ROS), depolariza-
tion of the inner mitochondrial membrane (Dwm) and
apoptosis in neuroblastoma monolayers and spheroids [6–
8]. This ROS production was scavenged by Trolox, a cell-
permeable and water-soluble vitamin E derivate, and this
attenuated the loss of viability by 4HPR, suggesting that
ROS plays a role in apoptosis induction by 4HPR in neu-
roblastoma [6]. The underlying mechanism of 4HPR-
induced ROS production and mitochondrial depolarization,
however, has still to be elucidated.
The major sources of ROS are the mitochondrial respi-
ratory chain [9, 10], the radical-generating enzymes
xanthine/xanthine oxidase [11] and NADPH oxidase [12],
and the phospholipase A2-activated arachidonic acid
metabolism [13]. The inability of inhibitors of xanthine/
xanthine oxidase, NADPH oxidase and phospholipase A2
to suppress 4HPR-induced ROS generation excluded these
radical-producing systems from being major sources of
4HPR-induced ROS in cervical cancer cells [14]. In con-
trast, several lines of evidence indicate that mitochondria
play an important role in the cytotoxicity of 4HPR.
Inhibition of the mitochondrial respiratory chain reduces
the Dwm, which facilitates the formation of the mitochon-
drial permeability transition pore. This permeabilization of
the inner mitochondrial membrane induced by apoptotic
agents is considered to be one of the mechanisms by which
proapoptotic proteins are released from mitochondria [15,
16]. Oxidative stress-inducing agents have been shown to
increase the permeability of the inner mitochondrial mem-
brane and antioxidants effectively prevented mitochondrial
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ROS production, mitochondrial membrane permeabiliza-
tion and apoptosis [17–22]. Increase in the mitochondrial
membrane permeability, release of cytochrome c and
induction of the intrinsic apoptosis pathway have been
shown to be key events in 4HPR-induced cell death in some
cells [16, 23–25]. Nevertheless, it has been suggested that in
neuroblastoma cells, lipoxygenase (12-LOX) was involved
in 4HPR-induced ROS formation and that the ROS-induc-
ing process did not take place in mitochondria [26].
In this study, we investigated the mechanism of 4HPR-
induced ROS production in general and the effect of 4HPR
on the electron ﬂow through the mitochondrial respiratory
chain in particular. The electron ﬂow as a result of 4HPR-
incubation was studied in six neuroblastoma cell lines by
measuring the ATP production in situ in a ﬂux model of
digitonin-permeabilized neuroblastoma cells respiring on
speciﬁc substrates for either complex I (NADH-Q reduc-
tase) or complex II (succinate-Q reductase). The data
presented in this paper demonstrate the pivotal role of
mitochondria in 4HPR-induced ROS production and the
inhibition of mitochondrial respiration by 4HPR.
Materials and methods
Chemicals
MitoQ ([10-(4,5-dimethoxy-2-methyl-3,6-dioxo-cyclo-
hexa-1,4-dienyl)-decyl]-triphenyl-phosphonium methne-
sulfonate) and TPP (decyltriphenylphosphonium bromide)
wereakindgiftfromAntipodeanPharmaceuticals,Dunedin,
New Zealand. CM-H2DCFDA (chloromethyldichloro-
ﬂuorescein diacetate), JC-1 and TMRM were purchased
fromInvitrogen,MolecularProbes(Carlsbad,CA).Allother
chemicals were purchased from Sigma (St Louis, MO).
Cell culture
Three MYCN single copy neuroblastoma cell lines (FISK,
NASS, SY5Y) and three MYCN ampliﬁed neuroblastoma
cell lines (IMR32, SJ8, SJNB10) were cultured in RPMI-
1640 culture medium supplemented with 10% heat inacti-
vated fetal bovine serum, 50 U/ml penicillin/streptomycin,
4 mM glutamine (Gibco, Invitrogen, Carlsbad, CA) and
plasmocin (5.0 mg/l) (InvivoGen, San Diego, CA). Cells
were grown at 37 C in humidiﬁed air with 5% CO2; all
culture ﬂasks and plates were from Corning (Corning, NY).
Cells were plated and allowed to adhere overnight before
incubations were started. All neuroblastoma cell lines
were a generous gift of Prof. R. Versteeg (Department of
Human Genetics, Academical Medical Centre, Amsterdam,
The Netherlands). Rho zero cells, cultured from 143b
osteosarcoma cells, were a kind gift from Dr. L. Nijtmans
(Nijmegen Centre for Mitochondrial disorders, Nijmegen,
The Netherlands) and cultured on DMEM culture medium
supplemented with 10% heat inactivated fetal bovine
serum, 50 U/ml penicillin/streptomycin, 1 mM pyruvate,
4 mM glutamine and 50 lg/ml uridine under the conditions
described above [27]. All experiments were performed in
culture medium unless otherwise speciﬁed.
Mitochondrial ROS produced by 4HPR
ROS-production was measured in neuroblastoma and
Rho zero cells as described before, using the ﬂuorescent
dye CM-H2DCFDA, which reacts with a wide range of
radicals, after 2 h incubation with 4HPR (0–20 lM)
(neuroblastoma cells and Rho zero cells) with or without
MitoQ (1–8 lM) (neuroblastoma cells) [6, 28]. TPP was
used as a negative control for MitoQ [29].
IMR32 and SJNB10 cells were incubated with 4HPR
(10 lM) and/or the uncoupling agent Carbonyl cyanide
3-chlorophenylhydrazone (CCCP) (0–20 lM) for 4 h.
Subsequently, ROS production was measured using the
CM-H2DCFDA probe as described before [6].
MitoSOX selectively reacts with superoxide in the
mitochondria and was used to measure speciﬁc mitoc-
hondrially generated ROS. All cell lines were incubated for
4 h with 4HPR (0–20 lM), after which medium was
replaced by Hanks Buffered Salt Solution (HBSS) (Lonza,
Walkersville, MD) containing 1 lM MitoSOX for 10 min.
Subsequently, ﬂuorescence was measured in a plate reader
(BMG labtech, FLUOstar optima): excitation 510 nm,
emission 580 nm. Cells (NASS, SJ8, SJNB10) were cul-
tured and incubated 4 h with 20 lM 4HPR and/or 500 lM
Trolox, after which the ROS production was measured with
MitoSOX, as described above.
Mitochondrial respiratory chain
The ATP assay was performed essentially as described
by Wanders et al. [30] (Fig. 1). Neuroblastoma cells were
grown to conﬂuency and incubated 4 h with 4HPR
(0–30 lM). This incubation was repeated in the presence
of either Trolox (500 lM) or CCCP (5–20 lM). After
incubation, the cells were harvested and washed twice with
PBS, followed by addition of the reaction medium con-
taining 150 mM KCl, 25 mM Tris–HCl (pH 7.4), 2 mM
EDTA, 10 mM potassium phosphate, 1 mM ADP, 0.1%
(w/v) bovine serum albumin, 75 lg/ml digitonin and either
10 mM malate (plus 10 mM glutamate) or 10 mM succi-
nate (plus 50 lM rotenone). Reactions were allowed to
proceed for 30 min at room temperature, terminated with
perchloric acid, protein was removed by centrifugation,
and the acid protein-free supernatants were neutralized
808 R. Cuperus et al.[30]. Subsequently, ATP was measured ﬂuorimetrically as
described previously using a Cobas Fara centrifugal ana-
lyzer (Roche, Mannheim, Germany) [31]. Afterwards, the
samples were used for aspartate or malate measurements.
Aspartate was measured using the end-point method
described in Bergmeyer et al. [32]. This method uses
the subsequent conversion of aspartate to malate via oxa-
loacetate in a reaction mixture containing glutamate-
oxaloacetate-transaminase, malate dehydrogenase, NADH
and a-ketoglutarate. The decrease in NADH, as a conse-
quence of the reduction of oxaloacetate to malate by malate
dehydrogenase, was measured ﬂuorimetrically with a
Cobas Fara centrifugal analyzer. Quantiﬁcation was per-
formed by means of a standard curve.
Malate was determined ﬂuorimetrically (excitation at
365 nm, emission at 450 nm) on a Cobas Fara centrifugal
analyzer by the end-point measurement of the reduction of
NAD ? analogue 3-acetylpyridine adenine dinucleotide
(APAD) to APADH by malate dehydrogenase. The reac-
tion was performed in a 100 mM Tris–HCl buffer at pH 9
containing 0.1% Triton-X-100 and 1 mM APAD. Malate
was quantiﬁed by means of a standard curve. Protein
concentration was determined as described before, using
the BCA assay [6].
Inhibiting mitochondrial respiratory chain complexes
Cells were incubated with 10 lM 4HPR in combination
with rotenone (0–80 lM) (complex I inhibitor), Carboxin
(0–2 mM), TTFA (0–2 mM) (thenoyltriﬂuoroacetone)
(both complex II inhibitors) or antimycine A (0–40 lM)
(complex III inhibitor) for 4 h. After incubation, both ROS
generation and mitochondrial membrane potential were
measured with CM-H2DCFDA and JC-1, respectively, as
described before [6].
Measuring mitochondrial membrane potential
Cells were cultured and incubated with 4HPR (20 lM)
for 4 h in combination with either Trolox (500 lM) or
MitoQ (4 and 8 lM), after which the medium was
replaced by medium containing 10 lg/ml JC-1 and
mitochondrial membrane depolarization was measured
[6]. In addition, the mitochondrial membrane potential
was measured using 4 lM TMRM to conﬁrm the JC-1
data. Fluorescence was measured with excitation 550 nm
and emission 600 nm.
Measurement of cell viability
SJNB10 cells were incubated with different concentrations
4HPR (0–40 lM) and/or Trolox (500 lM). After 24 h, the
viability of the cells was measured using MTS assay
(Promega, Madison, WI) according to the manufacturer’s
protocol. MTS incubation lasted for 4 h at 37C. The
experiments were performed in quadruplicate.
Results
ROS production using mitoSOX and the mitochondrial
antioxidant MitoQ
Mitochondrial ROS production was measured using the
mitoSOX probe, a ROS probe that speciﬁcally detects
superoxide in mitochondria. A concentration dependent
increase of mitochondrial ROS after 4 h 4HPR incubation
was observed in all cell lines except FISK and SY5Y
(Fig. 2a). MitoQ is a speciﬁc mitochondrial antioxidant
that attaches to the mitochondrial membrane. To demon-
strate that the ROS production induced by 4HPR
Fig. 1 Schematic
representation of the
mitochondrial respiratory chain.
After permeabilization of the
cells with digitonin, the electron
ﬂow through the different
complexes was measured.
Complex I NADH reductase.
Complex II succinate
dehydrogenase. Complex III
cytochrome c reductase.
Complex IV cytochrome c
oxidase. Complex V ATP
synthase. MDH malate
dehydrogenase. GOT glutamate-
oxaloacetate transaminase
4HPR-induced inhibition of mitochondrial respiration 809incubation is indeed generated mitochondrially, cells were
pre-incubated with MitoQ followed by co-incubation with
4HPR. 4HPR-induced ROS production, measured using the
CM-H2DCFDA probe, was scavenged when cells were pre-
incubated for 2 h with 1 lM MitoQ (Fig. 2b). The degree
of protection against ROS varied considerably between the
various cell lines. A moderate protective effect of MitoQ
on ROS scavenging was observed in SJNB10 and SY5Y.
However, increasing the concentration of MitoQ up to
8 lM resulted in a complete protection against 4HPR-
induced ROS in SJNB10 cells and SY5Y cells (Fig. 3a).
The protective effect of mitoQ in SY5Y cells was not
observed when cells were incubated with mitoQ and 4HPR
separately (Fig. 3b), indicating a low retention of mitoQ in
SY5Y cells. The apparent inability of mitoSOX to detect
superoxide in mitochondria in SY5Y cells might be caused
by low accumulation or retention of mitoSOX in mito-
chondria in SY5Y cells, as observed for mitoQ. Thus, our
data suggest that ROS production induced by 4HPR is
formed mitochondrially in our panel of neuroblastoma
cells.
ROS-production studied in Rho zero cells
In Rho zero cells, cultured from osteosarcoma cells, the
4HPR-induced ROS production was measured to investi-
gate whether ROS production is due to a speciﬁc effect of
4HPR on the respiratory chain. After 4 h incubation with
5 lM 4HPR, hardly any ROS production was observed in
Rho zero cells when compared to control osteosarcoma
cells (Fig. 4). In addition, 4HPR-induced ROS production,
measured using the CM-H2DCFDA probe, was scavenged
Fig. 2 Mitochondrial ROS generation after 4HPR incubation. a
Mitochondrial superoxide production measured by mitoSOX after 4 h
incubation with 0 lM( black bars), 10 lM( grey bars)o r2 0lM
(white bars) 4HPR. b The effect of the speciﬁc mitochondrial probe
mitoQ against ROS in cell lines incubated for 2 h with (open square)
or without (black diamond)1lM mitoQ followed by co-incubation
for 2 h with 0–20 lM 4HPR. ROS was measured using the DFCDA
probe. Each ﬁgure represents the mean ± SD of three experiments
Fig. 3 Scavenging of mitochondrial ROS by mitoQ. a SJNB10 and
SY5Y cells were incubated for 2 h with MitoQ followed by co-
incubation for 2 h with 20 lM 4HPR. Control black bars; 4HPR dark
grey bars; 4HPR and MitoQ (4 lM) light grey bars; 4HPR and
MitoQ (8 lM) white bars. b SJNB10 and SY5Y cells were pre-
incubated for 2 h with MitoQ followed by culturing in mitoQ-free
medium for 1 h and subsequently incubation with 20 lM 4HPR for
2 h. Control black bars; 4HPR dark grey bars; 4HPR and MitoQ
(4 lM) light grey bars; 4HPR and MitoQ (8 lM) white bars. Each
bar represents the mean ± SD of three experiments
810 R. Cuperus et al.when the control osteosarcoma cells were pre-incubated for
2 h with 1 lM MitoQ followed by co-incubation with
10 lM 4HPR. Thus, a functional mitochondrial respiratory
chain is required for 4HPR-induced ROS production.
Inhibition of the mitochondrial respiratory chain
complexes
To investigate which complexes of the mitochondrial
respiratory chain are involved in 4HPR-induced ROS
production, we studied the effect of 4HPR on the electron
ﬂux through the respiratory chain in digitonin-permeabili-
zed cells (Fig. 1).
The effect on aspartate formation and ATP synthesis
was measured using malate as a substrate for the mito-
chondrial respiratory chain in combination with glutamate.
The effect of 4HPR on the formation of aspartate, which is
the end-product of malate oxidation when malate oxidation
is studied in the presence of glutamate (Fig. 1), and ATP
synthesis was investigated. 4HPR inhibited aspartate pro-
duction in a similar concentration-dependent manner as
observed for the ATP production in all six cell lines
(Fig. 5a).
In order to demonstrate that the inhibition of 4HPR
was not restricted to complex I-mediated ATP synthesis,
we subsequently determined the effect of 4HPR on ATP
synthesis when the complex II substrate succinate was
used as electron donor for the mitochondrial respiratory
chain (Fig. 1). Rotenone was included in the reaction
medium to inhibit the electron ﬂow through complex I. In
all cell lines a concentration-dependent decrease of ATP
and malate synthesis was observed as a consequence of
4HPR incubation (Fig. 5b), although in FISK cells a less
potent decrease of malate compared to that of ATP was
observed.
To investigate whether the decreased ﬂux through the
mitochondrial respiratory chain combined with the
decreased ATP production was due to complex V (ATP
synthase) inhibition by 4HPR, the cells were incubated
with the uncoupling agent CCCP. ATP production fol-
lowed by CCCP incubation was decreased to \20%
(Fig. 6). As expected, aspartate and malate production was
not decreased when incubated with only CCCP. In the
presence of CCCP, a decrease was still observed in malate
and aspartate production after 4HPR incubation (Fig. 6).
Therefore, the decreased ﬂux through the mitochondrial
respiratory chain combined with the decreased ATP pro-
duction was not due to complex V (ATP synthase)
inhibition by 4HPR.
Surprisingly, the 4HPR-induced inhibition of the mito-
chondrial respiratory chain also occurred in FISK cells,
which hardly produced any mitochondrial ROS following
4HPR treatment. However, the 4HPR concentrations
required for inhibition of the electron ﬂux were much
higher than the optimal 4HPR concentrations inducing
mitochondrial ROS production, which were 10–30 and 5–
10 lM, respectively. These results demonstrate that 4HPR
inhibited the electron ﬂux through the mitochondrial
respiratory chain between Co-enzyme Q and complex IV
and that this inhibition was not required for the mito-
chondrial ROS production.
ROS scavenging and the effects on the mitochondrial
respiratory chain
Co-incubation with 4HPR and CCCP did not result in a
decreased ROS production (data not shown). Thus,
uncoupling the mitochondrial membrane did not prevent
ROS production, which indicates that 4HPR-induced ROS
production is not the result of inhibition of complex V of
the mitochondrial respiratory chain. Trolox is an antioxi-
dant that scavenged the 4HPR-induced ROS in
neuroblastoma [6]. The decrease of the mitochondrial
membrane potential induced by 4HPR could not be pre-
vented by Trolox or MitoQ (data not shown) [6]. The
activity of the mitochondrial respiratory chain in cells
incubated with the combination of 4HPR and Trolox was
investigated, and Trolox did not prevent the decrease of
aspartate-ATP and malate-ATP (data not shown). In con-
trast, in cells incubated with low concentrations 4HPR (0–
10 lM), the viability loss is attenuated by Trolox. How-
ever, when cells were incubated with higher 4HPR
concentrations (20–40 lM), the loss of viability could not
be fully prevented by Trolox (Fig. 7). These data suggest
that the cytotoxicity of 4HPR is exerted through the gen-
eration of ROS at low concentrations of 4HPR, whereas
inhibition of the mitochondrial respiratory chain might play
a role at high concentrations of 4HPR.
Fig. 4 ROS production in Rho zero cells (open square) and control
cells (black diamond) measured after 4 h incubation with 0–20 lM
4HPR. ROS was measured using the DFCDA probe. The amount of
ROS was expressed relative to that in untreated cells. Each ﬁgure
represents the mean ± SD of three experiments
4HPR-induced inhibition of mitochondrial respiration 811Fig. 5 The effect of 4HPR on ATP synthesis and aspartate formation
(complex I) and ATP synthesis and malate formation (complex II) in
digitonin-permeabilized neuroblastoma cells. All cell lines were
treated with 0–30 lM 4HPR for 4 h. To measure the ﬂux through
complex I–V and II–V, malate (plus glutamate) and succinate (plus
rotenone) were used as substrates, respectively, and the products
a Aspartate (black diamond)-ATP (open square) and b malate (black
square)-ATP (open square) were measured. Each ﬁgure represents
the mean ± SD of three experiments
812 R. Cuperus et al.Speciﬁc inhibition of the mitochondrial respiratory
chain complexes
To investigate the role of each complex in the 4HPR-
induced ROS production, the neuroblastoma cells were
incubated with speciﬁc inhibitors of complex I, II and III.
Carboxin and TTFA, two inhibitors of complex II, were the
only mitochondrial respiratory chain complex inhibitors
that reduced the 4HPR-induced ROS production (Fig. 8).
Rotenone and antimycin A, inhibitors of complex I and
complex III (cytochrome reductase), respectively, did not
reduce the ROS production (data not shown). A similar
protective effect of the complex II inhibitor TTFA on
4HPR-induced ROS formation was observed in other
neuroblastoma cell lines such as IMR32, SJNB10, NASS,
SY5Y and FISK (as well as in the osteosarcoma control
cells). This result is in line with the observation that
mitochondrial ROS production and inhibition of the elec-
tron ﬂux through the mitochondrial respiratory chain are
two independent mechanisms of 4HPR.
Fig. 6 The effect of 4HPR on
ATP and aspartate, and ATP
and malate synthesis in
digitonin-permeabilized SY5Y
and SJNB10 cells incubated for
4 h with the uncoupling agent
CCCP (5 lM for malate–ATP,
15 lM for aspartate–ATP in
SJNB10, 20 lM for aspartate–
ATP in SY5Y) and 0–30 lM
4HPR. a Aspartate (black
triangle) –ATP(open square)
and b malate (black triangle)–
ATP (open square). Each ﬁgure
represents the mean ± SD of
three experiments
Fig. 7 Effect of Trolox on loss of viability in 4HPR-treated cells.
SJNB10 cells were incubated with 0–40 lM 4HPR with (grey bars)
or without (black bars) 500 lM Trolox for 24 h. Viability was
measured using the MTS method and was depicted as percentage of
control. Each ﬁgure represents the mean ± SD of four experiments
4HPR-induced inhibition of mitochondrial respiration 813Discussion
In this paper, we have performed an in depth analysis of the
role of mitochondria in 4HPR-induced ROS formation.
Using the speciﬁc mitochondrial ROS-probe, MitoSOX,
we showed that 4HPR-induced ROS is of mitochondrial
origin in our panel of neuroblastoma cell lines. As Mit-
oSOX detects primarily superoxide, our results are in
apparent contrast with those of others who suggested that
hydrogen peroxide is produced as a result of 4HPR incu-
bation [14, 24]. The pivotal role of mitochondria in 4HPR-
induced ROS formation was further strengthened by the
scavenging effect of MitoQ, a speciﬁc mitochondrial
antioxidant. Furthermore, the fact that Rho zero osteosar-
coma cells were unable to produce as much ROS as their
control cells indicated that for ROS production to occur a
functional mitochondrial respiratory chain is required.
Our ﬁnding that ROS production is reduced by the
complex II inhibitors Carboxin and TTFA suggests that
complex II is the major source of 4HPR-induced ROS
formation in neuroblastoma. It should be noted that the
difference between the efﬁcacy of the complex I and II
inhibitors in ROS formation might be due to the fact that
electrons channelled through complex II produce about
four times more superoxide than those channelled through
complex I [33, 34]. Suzuki et al. [14] suggested that 4HPR
activated ROS generation in mitochondria at the Co-
enzyme Q site, complex III or both in cervical cancer. In
leukemia cells 4HPR-induced ROS production has been
suggested to occur between complex I and II [35]. Our
results demonstrate a major role for complex II in the
generation of ROS.
Our results are in apparent contrast with those of Lovat
et al. [36, 37], who stated that lipoxygenase (12-LOX) was
the mediator of 4HPR-induced ROS in SY5Y neuroblas-
toma cells and that the ROS-inducing process did not take
place in the mitochondria. Inhibitors of 12-LOX and
phospholipase A2 blocked 4HPR-induced apoptosis.
However, in cervical cells inhibition of phospholipase A2
was unable to suppress 4HPR-induced ROS [14].
Analysis of the electron ﬂux through the mitochondrial
respiratory chain in situ, using digitonin-permeabilized
neuroblastoma cells, showed a strong concentration-
dependent decrease in ATP synthesis in mitochondria
selectively respiring on either the complex I substrate
malate (plus glutamate) or the complex II substrate succi-
nate (plus rotenone). Parallel measurement of either the
complex I-mediated production of aspartate or the complex
II-mediated production of malate showed a decrease in
synthesis of both products. Combining 4HPR with the
uncoupling agent CCCP demonstrated that the inhibiting
effect did not take place in complex V, as the inhibition in
aspartate and malate oxidation by 4HPR is not alleviated
by CCCP. These data suggest that 4HPR inhibits the
mitochondrial respiratory chain between Co-enzyme Q and
complex IV (cytochrome oxidase). Previously, the effect of
4HPR-induced ROS generation on the mitochondrial
respiratory chain has been examined to some extent in
cervical cancer cells and leukemia cells, and the main
target site of 4HPR was located ‘downstream’ of mito-
chondrial respiratory chain complexes I and II and
‘upstream’ of complexes III and IV, possibly at the coen-
zyme Q site of the mitochondrial respiratory chain [14, 35].
No scavenging effect of CCCP on 4HPR-induced ROS
production was observed in our study. This is in contrast
with the fact that CCCP inhibits ROS formation induced by
4HPR in cervical cancer cells, which strongly supports the
conclusion that 4HPR acts as a pro-oxidant via the mito-
chondrial respiratory chain [14]. The uncoupling proton
ionophore CCCP can ‘short-circuit’ the proton current so
that both the proton gradient and membrane potential
across the inner mitochondrial membrane collapse. Con-
sequently, no phosphorylation of ADP can take place [38].
Fig. 8 The effect of complex II inhibitors on ROS production in
SJNB10 cells. Cells were incubated with (grey bars) or without (black
bars)1 0lM 4HPR for 4 h. a In combination with 0–2 lM TTFA. b
In combination with 0–2 mM Carboxin. After incubation, ROS
production was measured using CM-H2DCFDA probe. Percentage of
ROS induction compared to control. Each ﬁgure represents the
mean ± SD of three experiments
814 R. Cuperus et al.Cytochrome c oxidase (Complex IV) subunit VI over-
expression in glioblastoma cells led to decreased ROS
production followed by decreased apoptosis by 4HPR. In
addition, cytochrome c oxidase subunit III was down-reg-
ulated by 4HPR in hepatoma cells, which was accompanied
by ROS production and apoptotic cell death [39, 40]. In this
respect, it is worthwhile to note that the oxidation of car-
diolipin by 4HPR has been suggested to occur, which would
result in inhibition of complex IV of the mitochondrial
respiratory chain [35]. An association between mitochon-
drial cardiolipin peroxidation and cytochrome c release has
been established [10, 41], which would be in line with the
4HPR-induced cytochrome c release in cervical carcinoma
cells, head and neck squamous carcinoma cells, leukemia
cells and neuroblastoma cells [14, 16, 23, 35, 37].
Previously, it has been shown that in leukemia cells and
cervical cancer cells, 4HPR decreased the mitochondrial
membrane potential in an antioxidant-sensitive pathway,
which indicated that 4HPR-induced ROS generation is
required for mitochondrial membrane depolarization [14,
42]. However, in neuroblastoma cells, depolarization of the
mitochondrial membrane potential was not attenuated by
Trolox or by MitoQ, nor was the inhibition of 4HPR on the
mitochondrial respiratory chain scavenged by Trolox. This
indicates that in neuroblastoma cells ROS is not the cause
of the inhibition of the mitochondrial respiratory chain and
the mitochondrial depolarization. This is in contrast with
Asumendi et al. [35] who suggested ROS production to be
the cause of mitochondrial alterations in leukemia. Our
results indicated that low concentrations of 4HPR
(\10 lM) induced ROS-production at complex II of the
mitochondrial respiratory chain in most cell lines; this
effect and the loss of viability is scavenged by Trolox.
High concentrations 4HPR ([20 lM) inhibited the mito-
chondrial respiratory chain, which is not scavenged by
Trolox, nor is the loss of viability in cells treated with high
concentrations 4HPR. In addition, the inhibition of the
mitochondrial respiratory chain might result in the disap-
pearance of the mitochondrial membrane potential.
In HeLa cells, 4HPR does not induce mitochondrial
membrane permeabilization through a direct action of
4HPR on mitochondria or on the mitochondrial perme-
ability transition pore complex. Thus, in HeLa cells the
ability of 4HPR to generate ROS, mitochondrial depolar-
ization, and permeabilization must involve mediators
generated outside of mitochondria, such as ceramide,
lipoxygenase and ROS [23].
In this paper, we showed that 4HPR-induced ROS pro-
duction in neuroblastoma cells mainly takes place in the
mitochondria, more precisely, at complex II of the mito-
chondrial respiratory chain. At low concentrations of
4HPR, the cytotoxicity of 4HPR was exerted through
the generation of mitochondrial ROS, whereas high
concentrations of 4HPR were associated with inhibition of
the mitochondrial respiratory chain.
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